PT77370B - Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same - Google Patents

Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same

Info

Publication number
PT77370B
PT77370B PT77370A PT7737083A PT77370B PT 77370 B PT77370 B PT 77370B PT 77370 A PT77370 A PT 77370A PT 7737083 A PT7737083 A PT 7737083A PT 77370 B PT77370 B PT 77370B
Authority
PT
Portugal
Prior art keywords
same
pharmaceutical preparations
preparations containing
preparing new
new pyrazolo
Prior art date
Application number
PT77370A
Other languages
English (en)
Portuguese (pt)
Other versions
PT77370A (en
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of PT77370A publication Critical patent/PT77370A/pt
Publication of PT77370B publication Critical patent/PT77370B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT77370A 1982-09-22 1983-09-21 Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same PT77370B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23375/82A IT1154024B (it) 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione

Publications (2)

Publication Number Publication Date
PT77370A PT77370A (en) 1983-10-01
PT77370B true PT77370B (en) 1986-04-21

Family

ID=11206534

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77370A PT77370B (en) 1982-09-22 1983-09-21 Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same

Country Status (10)

Country Link
US (1) US4612318A (enExample)
EP (1) EP0104522B1 (enExample)
JP (1) JPS5989679A (enExample)
AT (1) ATE63913T1 (enExample)
CA (1) CA1248532A (enExample)
DE (1) DE3382299D1 (enExample)
ES (1) ES8503685A1 (enExample)
GR (1) GR78987B (enExample)
IT (1) IT1154024B (enExample)
PT (1) PT77370B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
US4751226A (en) * 1985-09-12 1988-06-14 Fujisawa Pharmaceutical Co., Ltd. Pyrazoloisoquinoline derivatives, plant growth regulating compositions, and method of use therefor
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
WO1989003385A1 (fr) * 1987-10-13 1989-04-20 Yoshitomi Pharmaceutical Industries, Ltd. Composes de pyrazole fusionnes, procede de preparation et utilisation en medecine
TW370529B (en) 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
ES2135062T3 (es) * 1994-06-16 1999-10-16 Pfizer Pirazolo y pirrolopiridinas.
WO2001098301A1 (en) * 2000-06-20 2001-12-27 Japan Tobacco Inc. Pyrazolopyridine compounds and use thereof as drugs
JPWO2003020313A1 (ja) * 2001-09-04 2004-12-16 小野薬品工業株式会社 スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤
DK1522314T3 (da) * 2002-06-26 2014-05-26 Ono Pharmaceutical Co Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
KR100844864B1 (ko) 2004-02-27 2008-07-09 에프. 호프만-라 로슈 아게 헤테로아릴-융합 피라졸로 유도체
CN1926139A (zh) * 2004-02-27 2007-03-07 霍夫曼-拉罗奇有限公司 稠合吡唑衍生物
KR20060114022A (ko) 2004-02-27 2006-11-03 에프. 호프만-라 로슈 아게 인다졸 유도체 및 그들을 함유하는 약학 조성물
JP2009506007A (ja) 2005-08-25 2009-02-12 エフ.ホフマン−ラ ロシュ アーゲー p38MAPキナーゼ阻害剤及びその使用方法
EP2468748B1 (en) * 2006-02-15 2016-05-25 AbbVie Inc. Pyrazoloquinolones are potent parp inhibitors
WO2010078427A1 (en) * 2008-12-30 2010-07-08 Arqule, Inc. Substituted pyrazolo [3, 4-b] pyridine compounds
CN102325755B (zh) 2008-12-30 2015-07-01 艾科尔公司 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物
WO2011159864A1 (en) * 2010-06-17 2011-12-22 Bracco Imaging S.P.A. Jte013 analogs and methods of making and using same
RU2495039C1 (ru) * 2012-07-31 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-1,6-ДИФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-6-СТИРИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
IL302355A (en) * 2017-08-23 2023-06-01 Sprint Bioscience Ab Azaindolylpyridone and diazaindolylpyridone compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403158A (en) * 1966-03-11 1968-09-24 Upjohn Co 1h-pyrazolo[3, 4-b]pyridines
US3681368A (en) * 1970-10-15 1972-08-01 Abbott Lab Pyrazolo naphthridines
BE787249A (fr) * 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3891630A (en) * 1974-03-04 1975-06-24 Abbott Lab Substituted pyrazolo{8 3,4-e{9 {8 1,4{9 thiazepines and isoxazolo{8 5,4-e{9 {8 1,4{9 thiazepines
US3903096A (en) * 1974-03-29 1975-09-02 Squibb & Sons Inc New derivatives of sulfonyl-, sulfinyl- and sulfenyl-1H-pyrazolo {8 3,4-b{9 -pyridines
EP0005745B1 (en) * 1978-05-26 1982-07-14 Gruppo Lepetit S.P.A. Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ATE63913T1 (de) 1991-06-15
IT8223375A0 (it) 1982-09-22
EP0104522A3 (en) 1985-06-19
GR78987B (enExample) 1984-10-02
JPS5989679A (ja) 1984-05-23
EP0104522A2 (en) 1984-04-04
PT77370A (en) 1983-10-01
CA1248532A (en) 1989-01-10
ES525786A0 (es) 1985-03-01
EP0104522B1 (en) 1991-05-29
ES8503685A1 (es) 1985-03-01
IT1154024B (it) 1987-01-21
DE3382299D1 (de) 1991-07-04
US4612318A (en) 1986-09-16

Similar Documents

Publication Publication Date Title
PT77370A (en) Process for preparing new pyrazolo &lt;3,4-b&gt; piridine derivatives and pharmaceutical preparations containing the same
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
HUT44493A (en) Process for production of new derivatives of cycloalcane (1,2-b) indol-sulphinamid and medical preparatives containing these compounds
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
IE832529L (en) ß-CARBOLINES, PROCESS FOR THEIR PRODUCTION AND¹PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
SG69193G (en) Process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof,compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions
HUT47114A (en) Process for producing podophyllotoxin and podophyllotoxin derivatives
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
AU581855B2 (en) 1-(4&#39;-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
IE43872L (en) 2,9-dioxatricyclo [4.3.1.0(3,7)] decanes
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
JPS56122357A (en) 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
AU635463B2 (en) 2-amino-t trahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical compositions containing same
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
AU585418B2 (en) 6H-isoxazolo`` 3,4-d`` pyrazolo`` 3,4-b`` pyridines,a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930422